Clinical/Laboratory Parameters: | Overall cohort (n= 379) | Outcome diagnostic category | |||
---|---|---|---|---|---|
Non-PIA ( n = 217); | PIA ( n = 162); | P -value† | |||
Age (years) | |||||
-cat; >50 (%) | 51 | 49 | 51 | 0.533 | |
-cont; mean (SD) | 50.9 (36 to 66.) | 48.5 (34.5 to 62.5) | 53.8 (37.8 to 69.8) | 0.057 | |
Sex; F (%) | 69 | 71 | 67 | 0.540 | |
Ever smoked? (%) | 54.1 | 100, 117 | 74, 88 | 0.999 | |
Sx durn (weeks) | |||||
-cat; ≥20 (%) | 51 | 61 | 38 | <0.001 | |
-cont; median (IQR) | 20 (10 to 34) | 24 (12 to 52) | 12 (8 to 24) | <0.001 | |
TJC /72 | |||||
-cat; >6 (%) | 51 | 48 | 54 | 0.299 | |
-cont; median (IQR) | 7 (2 to 14) | 6 (2 to 14) | 7.5 (3 to 15) | 0.052 | |
SJC /72 | |||||
-cat; ≥1 (%) | 46 | 26 | 73 | <0.001 | |
-cont; median (IQR) | 0 (0 to 3) | 0 (0 to 1) | 2 (0 to 6) | <0.001 | |
JPS | |||||
-cat; ≥2 (%) | 66 | 56 | 78 | <0.001 | |
-cont; median (IQR) | 2 (1.5 to 2) | 2 (1.5 to 2) | 2 (2 to 2.5) | <0.001 | |
EMS (hours) | |||||
-cat; ≥1 (%) | 50 | 39 | 65 | <0.001 | |
-cont; median (IQR) | 1 (0.2 to 2) | 0.5 (0.05 to 1.5) | 1 (0.5 to 2) | <0.001 | |
CRP (g/l) | |||||
-cat; <5,5 to 14,≥14 (%) | 49,26,25 | 66, 23, 11 | 25, 30, 45 | <0.001 | |
-cont; median (IQR) | 5 (<5 to 14) | <5 (<5 to 8) | 11 (<5 to 32) | <0.001 | |
ESR (mm/hr) | |||||
-cat; >24 (%) | 50 | 33 | 72 | <0.001 | |
-cont; median (IQR) | 24 (13 to 50) | 18 (9 to 13) | 45 (24 to 67) | <0.001 | |
RF; Pos (%) | Neg, Pos | 193, 24 | 97, 65 | <0.001 | |
ACPA; Pos (%) | Neg, Pos | 216, 1 | 107, 55 | <0.001 | |
MSUS Parameters Domain/Parameter Definition | |||||
Grey-sale synovotis | ∑ semi-quant. score/16 joints: ≥2 (%) | 35.1 | 19.4 | 56.2 | <0.001 |
∑ semi-quant score/6 joints (worst hand): ≥2 (%) | 29.6 | 15 | 48.8 | <0.001 | |
Number of joints/16 scoring ≥1: ≥3 (%) | 30.1 | 14.7 | 50.6 | <0.001 | |
Power Doppler synovitis | ∑ semi-quant. Score/16 joints: ≥1 (%) | 29 | 15.7 | 46.9 | <0.001 |
Number of joints/16 scoring ≥1: ≥2 (%) | 16.9 | 7.4 | 29.6 | <0.001 |